In neurons, TRIM66 regulates the activity of SIRT6, a histone-deacetylating enzyme that is involved in epigenetic processes and has been recently suggested as a novel drug target for MS [65,66]. This evidence concerns the gene SIRT6 and myeloid sarcoma.